Clinical Research Directory

Inclusion Criteria: * Live in New Zealand. * Vape nicotine at least weekly (one or more days out of the past seven days). * Used to smoke (i.e. they have smoked tobacco regularly but not at all in the past six months) or have never smoked (i.e., they have never been a regular user of smoked tobacco, defined as less than 100 cigarettes in their lifetime). * Are aged ≥16 years. * Are motivated to quit vaping in the next eight weeks. * Are able to provide consent. * Have access to the internet via a computer or smart phone. * Are a registered patient at a New Zealand medical facility. Exclusion Criteria: * They have another person in their household currently enrolled in the study. * They smoke tobacco currently or were a recent regular user of tobacco. * They are enrolled in another vaping cessation programme/trial. * They self-report having had a serious cardiovascular event, or hospitalisation for a cardiovascular complaint, in the previous four weeks (e.g. stroke, myocardial infarction, unstable angina, cardiac arrhythmia, coronary artery bypass graft and angioplasty). * They self-report uncontrolled hypertension. * They have a strong preference to use/not use NRT or nicotine tapering. * They are current users of smoking cessation pharmacotherapy (e.g. NRT, varenicline, cytisine, nortriptyline \[including if it is used for a different indication\], and amitriptyline \[as it converts to nortriptyline\]. * They are currently enrolled in another vaping cessation programme/trial.